The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Abstract
OBJECTIVE: To assess the efficacy of buprenorphine for short-term maintenance/detoxification. DESIGN: A randomized, double-blind, parallel group study comparing buprenorphine, 8 mg/d, methadone, 60 mg/d, and methadone, 20 mg/d, in a 17-week maintenance phase followed by an 8-week detoxification phase. SETTING: Outpatient facilities at the Addiction Research Center, Baltimore, Md. PATIENTS: One hundred sixty-two volunteers seeking treatment for opioid dependence. INTERVENTION: In addition to the medication, counseling using a relapse prevention model was offered but not required. PRIMARY OUTCOME MEASURES: Retention time in treatment, urine samples negative for opioids, and failure to maintain abstinence. RESULTS: Throughout the maintenance phase, retention rates were significantly greater for buprenorphine (42%) than for methadone, 20 mg/d (20%, P less than .04); the percentage of urine samples negative for opioids was significantly greater for buprenorphine (53%, P less than .001) and methadone, 60 mg/d (44%, P less than .04), than for methadone, 20 mg/d (29%). Failure to maintain abstinence during the maintenance phase was significantly greater for methadone, 20 mg/d, than for buprenorphine (P less than .03). During the detoxification phase, no differences were observed between groups with respect to urine samples negative for opioids. For the entire 25 weeks, retention rates for buprenorphine (30%, P less than .01) and methadone, 60 mg/d (20%, P less than .05), were significantly greater than for methadone, 20 mg/d (6%). All treatments were well tolerated, with similar profiles of self-reported adverse effects. The percentages of patients who received counseling did not differ between groups. CONCLUSIONS: Buprenorphine was as effective as methadone, 60 mg/d, and both were superior to methadone, 20 mg/d, in reducing illicit opioid use and maintaining patients in treatment for 25 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel-Haenszel Procedure
Mantel, N. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500879 · Cited by 2,897
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Predicting Response to Alcohol and Drug Abuse Treatments: Role of Psychiatric Severity
McLellan, A. T. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010030004 · Cited by 805
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Martin, W. R. (1983) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06637-2 · Cited by 648
Naltrexone, an Antagonist for the Treatment of Heroin Dependence: Effects in Man
Martin, W. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360022003 · Cited by 392
Buprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.13 · Cited by 260
Self-citationBuprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20047-7 · Cited by 226
Self-citationLing, W. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060043007 · Cited by 211
Fudala, P. J., Jaffe, J. H., Dax, E. M., & Johnson, R. E. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.67 · Cited by 191
Self-citationBuprenorphine Suppresses Cocaine Self-Administration by Rhesus Monkeys
Mello, N. K., Mendelson, J. H., Bree, M. P., & Lukas, S. E. (1989) · Science · doi:10.1126/science.2772637 · Cited by 165
Buprenorphine effects on human heroin self-administration: an operant analysis.
Mello, N. K., Mendelson, J. H., & Kuehnle, J. C. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33287-8 · Cited by 157
Role of opioid antagonists in treating intravenous cocaine abuse
Kosten, T. R., Kleber, H. D., & Morgan, C. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90589-4 · Cited by 124
Buprenorphine detoxification from opiod dependence: A pilot study
Kosten, T. R., & Kleber, H. D. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90454-7 · Cited by 112
Assessment of Opioid Dependence with Naloxone
Peachey, J. E., & LEI, H. (1988) · British Journal of Addiction · doi:10.1111/j.1360-0443.1988.tb03981.x · Cited by 90
Heroin Addiction and the Role of Methadone in Its Treatment
D, A. G. M. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750220001001 · Cited by 89
Contingent methadone delivery: Effects on illicit-opiate use
Higgins, S. T., Stitzer, M. L., Bigelow, G. E., & Liebson, I. A. (1986) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(86)90080-3 · Cited by 87
Johnson, R. E., Cone, E. J., Henningfield, J. E., & Fudala, P. J. (1989) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1989.147 · Cited by 86
Self-citationMethadone Maintenance to Abstinence: How Many Make It?
Milby, J. B. (1988) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198807000-00003 · Cited by 81
High dose buprenorphine for postoperative analgesia
Budd, K. (1981) · Anaesthesia · doi:10.1111/j.1365-2044.1981.tb08867.x · Cited by 74
Retention Patterns in a Therapeutic Community for the Treatment of Drug Abuse
Sansone, J. (1980) · International Journal of the Addictions · doi:10.3109/10826088009040050 · Cited by 69
Patient Characteristics Associated with Retention in a Methadone Maintenance Program
Babst, D. V., Chambers, C. D., & WARNER, A. (1971) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1971.tb02386.x · Cited by 49
Factors Related to Successful Retention in Methadone Maintenance: A Review
Szapocznik, J., & Ladner, R. A. (1977) · International Journal of the Addictions · doi:10.3109/10826087709027271 · Cited by 43
Buprenorphine as new treatment for heroin dependence
Reisinger, M. (1985) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(85)90050-x · Cited by 36
Buprenorphine: a new maintenance opiate?
Seow, S. S. W., Quigley, A. J., Swensen, G., Harrison‐Stewart, A., Rappeport, L., Ilett, K. F., & Dusci, L. J. (1986) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1986.tb128412.x · Cited by 34
Buprenorphine suppresses cocaine self-administration in rhesus monkeys.
Mello, N. K., Mendelson, J. H., Bree, M. P., & Lukas, S. E. (1989) · PubMed · Cited by 24
Impact of a multimodality treatment program for heroin addicts
Brown, B. S., DuPont, R. L., Bass, U. F., Glendinning, S. T., Kozel, N. J., & Meyers, M. B. (1972) · Comprehensive Psychiatry · doi:10.1016/0010-440x(72)90010-7 · Cited by 19
Childress, A. R., McLellan, A. T., WOODY, G. E., & O’Brien, C. P. (1991) · PsycEXTRA Dataset · doi:10.1037/e496292006-009 · Cited by 9
Cited by
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773
Drug Transfer and Metabolism by the Human Placenta
Syme, M. R., Paxton, J. W., & Keelan, J. A. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443080-00001 · Cited by 634
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Self-citationFudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577
Metadata
- Authors
- Johnson, R. E.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1992-05-27
- Volume
- 267
- Issue
- 20
- Pages
- 2750
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1979184030
- Cited by
- 572
- References
- 32
- FWCI
- 24.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.